Dr. Haseeb Ahmed

24/07/2026

21/07/2026

Some insight on Correct Use Of Insulin pen

18/07/2026

Cushing Syndrome vs Addison’s Disease | Complete Endocrine Disorder Comparison

17/07/2026

16/07/2026

FDA approves Merck's daily cholesterol pill 💊

💊 A major breakthrough in cholesterol treatment has arrived.

The US FDA has approved Merck's once-daily cholesterol pill, Lipfendra (enlicitide)—the first oral PCSK9 inhibitor—giving eligible patients a new alternative to cholesterol-lowering injections.

❤️ For millions living with high LDL ("bad") cholesterol, this could make advanced treatment far more convenient. Instead of regular injections, eligible patients may now have the option of taking a once-daily pill.

🩺 The approval is based on late-stage clinical trials showing the medicine significantly lowers LDL cholesterol in a broad range of patients, including those already taking statins and people with familial hypercholesterolemia.

📈 But that's not the only story. The approval is also a major milestone for Merck as it prepares for the future beyond its blockbuster cancer drug, Keytruda, which begins losing key patent protection from 2028.

❓Who can take this medicine? How does it work? Can it replace injections? What do experts expect next? And why are cardiologists around the world watching its long-term results so closely?

👉 Read the full story on Medical News Pakistan: https://www.medicalnews.pk/16-Jul-2026/fda-approves-merck-s-once-daily-cholesterol-pill-offering-alternative-injections

📲 Follow Medical News Pakistan on WhatsApp for real-time health alerts, medical breakthroughs and expert updates: https://whatsapp.com/channel/0029VbArFeUFCCoaD7rQbU0q

15/07/2026

06/12/2025